Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1984 1
1985 1
1987 1
1988 1
1989 3
1990 1
1992 3
1993 1
1994 1
1995 9
1997 2
1998 5
1999 1
2000 2
2001 2
2002 2
2004 1
2005 7
2006 3
2007 5
2008 4
2009 4
2010 3
2011 2
2012 5
2013 8
2014 3
2015 6
2016 3
2017 4
2018 2
2019 1
2020 3
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
Mah JK, Clemens PR, Guglieri M, Smith EC, Finkel RS, Tulinius M, Nevo Y, Ryan MM, Webster R, Castro D, Kuntz NL, McDonald CM, Damsker JM, Schwartz BD, Mengle-Gaw LJ, Jackowski S, Stimpson G, Ridout DA, Ayyar-Gupta V, Baranello G, Manzur AY, Muntoni F, Gordish-Dressman H, Leinonen M, Ward LM, Hoffman EP, Dang UJ; NorthStar UK Network and CINRG DNHS Investigators. Mah JK, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2144178. doi: 10.1001/jamanetworkopen.2021.44178. JAMA Netw Open. 2022. PMID: 35076703 Free PMC article. Clinical Trial.
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
McDonald CM, Henricson EK, Abresch RT, Florence J, Eagle M, Gappmaier E, Glanzman AM; PTC124-GD-007-DMD Study Group; Spiegel R, Barth J, Elfring G, Reha A, Peltz SW. McDonald CM, et al. Among authors: abresch rt. Muscle Nerve. 2013 Sep;48(3):357-68. doi: 10.1002/mus.23905. Epub 2013 Jul 17. Muscle Nerve. 2013. PMID: 23674289 Free PMC article. Clinical Trial.
Exercise in neuromuscular diseases.
Abresch RT, Carter GT, Han JJ, McDonald CM. Abresch RT, et al. Phys Med Rehabil Clin N Am. 2012 Aug;23(3):653-73. doi: 10.1016/j.pmr.2012.06.001. Phys Med Rehabil Clin N Am. 2012. PMID: 22938880 Review.
Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary.
Finder J, Mayer OH, Sheehan D, Sawnani H, Abresch RT, Benditt J, Birnkrant DJ, Duong T, Henricson E, Kinnett K, McDonald CM, Connolly AM. Finder J, et al. Among authors: abresch rt. Am J Respir Crit Care Med. 2017 Aug 15;196(4):512-519. doi: 10.1164/rccm.201703-0507WS. Am J Respir Crit Care Med. 2017. PMID: 28636407 Review.
Chronic pain in persons with neuromuscular disease.
Hoffman AJ, Jensen MP, Abresch RT, Carter GT. Hoffman AJ, et al. Among authors: abresch rt. Phys Med Rehabil Clin N Am. 2005 Nov;16(4):1099-112, xii. doi: 10.1016/j.pmr.2005.08.015. Phys Med Rehabil Clin N Am. 2005. PMID: 16214063 Review. No abstract available.
Upper extremity reachable workspace evaluation with Kinect.
Kurillo G, Han JJ, Obdržálek S, Yan P, Abresch RT, Nicorici A, Bajcsy R. Kurillo G, et al. Among authors: abresch rt. Stud Health Technol Inform. 2013;184:247-53. Stud Health Technol Inform. 2013. PMID: 23400165
99 results